MBX Biosciences, Inc.
MBX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2024 | Q2 2023 |
|---|---|---|
| Net Income | -$15.86M | -$7.61M |
| EPS Diluted | -$12.62 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MBX Biosciences, Inc. · CIK 1776111 · Engraved from SEC EDGAR